Development of novel therapeutics for the treatment of human glioblastoma

  • Mazar, Andrew P (PD/PI)
  • James, Charles David (Co-PD/PI)
  • Raizer, Jeffrey J (Co-PD/PI)
  • Ugolkov, Andrey (Co-PD/PI)

Project: Research project

Project Details


Goals are to evaluate the novel GSK-3 inhibitor 9-ING-41 in combination with a panel of chemotherapeutic drugs used clinically to treat recurrent glioblastoma.
Effective start/end date1/1/1612/31/17


  • Northwestern Memorial Hospital (NMH Master #7/Exhibit B.8)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.